Memo Therapeutics and Ono Pharmaceutical enter partnership
Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.
Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.
The European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.
Catalonia’s healthcare start-ups raised 238m in 2021, a new record and 4% up from 2020. Four fifth (83%) of VC came from international investors.
Automotive company Audi AG and gas fermentation specialist Krajete GmbH are building a highly effective industrial-scale CO2 Direct Air Capturing plant in Linz.
Finnish Solar Foods Ltd has got the first ever novel food authorisation for its microbially-produced protein powder Solein.
Bone Therapeutics has merged with French inflammatory/autoimmune company Medsenic in a 40m deal and changed its name into BioSenic.
Cambridge-based Enhanc3D Genomics Ltd has raised £10m in Series A financing led by BGF and Parkwalk Advisors.
Belgian CDMO Univercells SA has raised 44m through the first close of its Series D financing round led by Belgian and international investors. I
German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.